Enjoy complimentary customisation on priority with our Enterprise License!
The acne drugs market size is estimated to grow at a CAGR of 3.46% between 2022 and 2027. The acne drugs market size is forecast to increase by USD 907.11 million. The growth of the market depends on several factors, including the emergence of improved diagnostic modalities, the launch of new acne drugs, and the increasing cases of acne.
This acne drugs market report extensively covers market segmentation by type (prescription drugs and OTC drugs), route of administration (topical and oral), and geography (North America, Europe, Asia, and Rest of World). It also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.
To learn more about this report, View Report Sample
The emergence of improved diagnostic modalities is notably driving the market growth, although factors such as the presence of substitutes for acne drugs may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The emergence of improved diagnostic modalities is notably driving market growth. When the diagnosis is not clear from the patient history or a simple physical examination, there are other methods for diagnosing skin diseases like acne. Due to its accuracy, sensitivity, and speed, a gene-specific polymerase chain reaction is the newest addition to dermatological drugs in modern molecular diagnostics. Dermatologists can now test for cellular and molecular mechanisms underlying acne in addition to the standard treatment, owing to molecular diagnosis. Additionally, molecular diagnostics have improved risk assessment and provided prognostic data.
The incorporation of molecular data has improved the use of genetic techniques in dermatologic conditions like acne. The resistance of the immune system to Propionibacterium acnes, a bacteria that encourage acne, can also be influenced by genetics. The development of next-generation sequencing technologies has also made it possible for dermatologists to use new diagnostic tools. Therefore, improvements in acne diagnosis methods will result in an increase in the number of patients receiving treatment. Hence, such factors will drive the demand for acne drugs and, in turn, the growth of the market during the forecast period.
The increasing research on gene therapy for dermatologic conditions is an emerging trend in the market growth. Due to developments in stem cell-based gene therapy for the treatment of genetic skin diseases, there has been an increase in research activities surrounding gene therapy for dermatological conditions. However, it is unclear how this strategy will perform clinically in the long run.
Acne is one of the many dermatological conditions that have been treated with gene therapy. Regulators like the National Institutes of Health (NIH) and the FDA place strict restrictions on these therapies. The improvements in the molecular characterization of dermatologic conditions have improved the knowledge of the pathogenetic mechanisms underlying skin diseases like acne. This will increase the R&D of new acne drugs and, in turn, will drive the growth of the market in focus during the forecast period.
The presence of substitutes for acne drugs is a major challenge impeding the market growth. Customers favor high-quality cosmetics that last for a long time, are less toxic, and have no negative effects on the skin. Additionally, as people's lifestyles have changed around the world, personal grooming at home has gained popularity, which has increased consumer demand for cosmetics like anti-acne face wash. Because of this, customers choose products with premium qualities even when they come at a high price.
Affluent consumers who are concerned about their facial appearance and nourishment and can afford such high-quality products at premium price points are the target market for premium cosmetic products. Vendors concentrate on increasing their presence in the premium segment in order to cover the entire spectrum of cosmetics. For specific skin problems like acne, excessive oil, and dryness, a variety of vendors offer high-end anti-acne cosmetics. For instance, Johnson and Johnson offers the Complete Acne Therapy System, which consists of three products, an oil-free moisturizer, an acne cleanser, and an acne control lotion, under the Neutrogena brand. Both men and women can use these products to control acne problems. These products fall under the category of premium products. Thus, anti-acne cosmetic appears as an alternative to acne drugs. Therefore, the adoption of anti-acne cosmetics is expected to hamper the market during the forecast period.
The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Global Acne Drugs Market Customer Landscape
Vendors are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
AndroScience Corp. - The company offers an androgen receptor and signal transducer and activation of the transcription pathway. The key offerings of the company include acne drugs such as ARD enhancers.
The report also includes detailed analyses of the competitive landscape of the market and information about 15 market vendors, including:
Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.
The market share growth by the prescription drugs segment will be significant during the forecast period. Prescription medications for acne reduce oil production, swelling, and inflammation while also treating bacterial infections. It can take months or even years for prescription acne medications to completely clear up acne.
Get a glance at the market contribution of various segments View the PDF Sample
The prescription drugs segment was valued at USD 2,437.63 million in 2017 and continued to grow until 2021. Topical medications containing retinoic acids or tretinoin may be included in prescription medications. These are available as creams, gels, and lotions and are helpful for treating moderate acne. Tretinoin (Avita, Retin-A, and other brands), adapalene (Differin), and tazarotene (Tazorac, Avage, and other brands) are a few examples. Oral medications, such as antibiotics to lower bacteria, are also included in prescription medications. The antibiotic of choice for treating acne is tetracycline (minocycline and doxycycline) or a macrolide (erythromycin and azithromycin). The use of prescription medications for the treatment of acne is also anticipated to increase due to the growing emphasis on a better understanding of dermatologic conditions at the molecular level. Thus, the availability of various drugs for acne treatment will drive the growth of the segment and, in turn, the market in focus during the forecast period.
For more insights on the market share of various regions Download PDF Sample now!
North America is estimated to contribute 38% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The key market-leading nations in North America for acne medications are the US, Canada, and Mexico. Young consumers between the ages of 20 and 34 dominate the markets in these nations. Acute treatment works well for the majority of acne patients in the area, and topical therapy can help keep acne under control over time. On the other hand, patients with severe high acne need to continue receiving systemic treatment. Therefore, the adoption of acne medications is likely to be boosted by access to treatments that are successful in treating visible lesions and scarring on facial skin.
Additionally, the prevalence of acne among teenagers and adults has increased the demand for acne medications. For instance, acne, which affects nearly 50 million Americans annually, is the most prevalent skin condition in the US. Thus, it is anticipated that during the forecast period, the region's high acne problems will fuel the growth of the regional market.
The outbreak of COVID-19 in 2020 negatively impacted the growth of the regional market. However, in 2021, the initiation of large-scale COVID-19 vaccination drives led to the lifting of lockdown restrictions in the region. This resulted in the resumption of clinical treatment for acne, which, in turn, positively impacted the growth of the market. Additionally, the launch of new drugs in the region by the vendors is also expected to drive the growth of the market in focus during the forecast period.
The acne drugs market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.
Technavio categorizes the global acne drugs market as a part of the pharmaceutical market within the overall healthcare industry. The parent pharmaceuticals market covers products and companies engaged in the R&D or production of generic drugs, non-generic drugs, and veterinary drugs. Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.
Acne Drugs Market Scope |
|
Report Coverage |
Details |
Page number |
145 |
Base year |
2022 |
Historic period |
2017-2021 |
Forecast period |
2023-2027 |
Growth momentum & CAGR |
Accelerate at a CAGR of 3.46% |
Market growth 2023-2027 |
USD 907.11 million |
Market structure |
Fragmented |
YoY growth 2022-2023(%) |
3.29 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 38% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
Key companies profiled |
AndroScience Corp., Astellas Pharma Inc., Bayer AG, Cipher Pharmaceuticals Inc., Cosmo Pharmaceuticals NV, Elorac Inc., Equalan Pharma Europe Sp. z o.o., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Journey Medical Corp., McKesson Corp., Paratek Pharmaceuticals Inc., Photocure ASA, Reckitt Benckiser Group Plc, Skinvisible Pharmaceuticals Inc., Teva Pharmaceutical Industries Ltd., Timber Pharmaceuticals LLC, Viatris Inc., and XBiotech Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Route of Administration
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.